Scout Bio
Biotechnology ResearchView the employees at
Scout Bio-
Lanice Evans Clinical Trial Coordinator
-
Jackson, Mississippi, United States
-
Rising Star
Jacky May, DVM Director Clinical Development at Scout Bio-
Savannah, Missouri, United States
-
Top 1%
Fran Gaconnier VP, Communications at Scout Bio-
Dallas, Texas, United States
-
Top 10%
Madelyn Franklin Research Specialist at Scout Bio-
Rising Star
Kara Claxton Clinical Trial Manager at Scout Bio-
Platte City, Missouri, United States
-
Rising Star
Overview
Scout’s mission is to harness the genetic revolution transforming human medicine to deliver the future of veterinary medicine. By combining world-leading talent in animal health and gene therapy technology, we have built a development platform for one-time therapies that address major areas of unmet medical need in pet medicine. We are a global company supported by leading life sciences investors and an R&D collaboration with the renowned Gene Therapy Program at the University of Pennsylvania. About Our Currently Enrolling Study for Cats Scout’s first therapy in development focuses on the anemia associated with chronic kidney disease (CKD) in cats. Our study is currently enrolling cats at participating clinics across the U.S. It involves a single injection (followed by 70 days of monitoring) and may relieve a cat’s anemia for life. Learn more about our study and find a participating clinic: www.scoutbio.co/catEPOstudy.
-